Joanne Lager, MD


Dr. Lager has more than 20 years of experience in oncology drug development including treatment of solid tumors and hematologic malignancies in all phases of development. She led strategy and operations for two mid-stage clinical programs and an emerging immuno-oncology pipeline as Chief Medical Officer at iTeos Therapeutics. As the Head of Development for Oncology…

Kelsey Chen, Ph.D, MBA


Dr. Chen has over 20 years of investment experience in healthcare. She served as Managing Director at Cormorant Asset Management, responsible for investing in both private and public biotech companies. Prior to Cormorant, she was a Portfolio Manager of Putnam Global Health Care Fund and Healthcare Sector Leader at Putnam Investments. She received her MBA…

Yan Lou, Ph.D


Dr. Lou has more than 15 years of experience in the biotechnology and pharmaceutical industry and is a seasoned scientific leader with broad knowledge and deep insight into drug discovery. He has led and championed multiple research projects at Principia Biopharma, Nurix Inc., Novartis, and Roche, contributing to the inventions of first-in-class lead molecules and…

Zhenhai Gao, Ph.D.

President & CEO

Dr. Gao has more than 20 years of experience in biotechnology and pharmaceutical industry, with a focus on cancer biology, cellular assay development, biomarker discovery and patient stratification. He has led oncology programs from target development to Phase I trials at many companies, including Incyte Corporation and Novartis Institutes for Biomedical Research. He received his…